News

The most basic impulse behind CER is the desire to control healthcare costs. The implications for the biopharma industry could be significant

Are you prepared?

Preventable medical and medication errors should figure more prominently in the current debate on healthcare reform

Central nervous system (CNS) medication for society’s oldest and youngest present special challenges

A fast-growing market supports more, and more comprehensive, data services

In whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully

Deloitte’s annual study of information security trends finds gaping holes in network security

Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations

IMS Health rolls out Global Message IQ service for syndicated market research

California pedigree delay proves fatal to pioneering IT firm

Biggest focus remains oncologic/immunologic and CNS drugs; about one in six candidates eventually gain approval, according to Tufts study

Approval marks an innovative buccal drug-delivery mechanism, as well as signaling how FDA might approach REMS for all opioids

Moisture control, time-temperature monitoring are among the application areas being driven by biotech products and others, says Freedonia Group

Manufacturers benefit as governments prepare for largescale vaccination campaigns

As it absorbs Genentech, Roche leaves PhRMA and joins BIO

Study is sponsored by IT vendor Axway

Companies collaborate on customized system tailored to the pharma supply chain

Advocacy group for compliance packaging want to build its membership

Consumers might get product recall information faster than healthcare professionals

Merrion Pharma announces good Phase II results at ASCO meeting

First decline since Armstrong & Associates began tracking the industry in 1996

Compliance jumps over last year’s top issue, competitive pressure, among healthcare supply-chain decisionmakers

New IDC study finds that Oracle is the now the top life-sciences IT vendor; meanwhile, are there ‘demons’ in the pharma supply chain?

The marketplace requirements for sales force structures are changing faster than the industry is evolving

Coming off a record-setting year, ABC stresses growth in generics, and services revolving around specialty pharmaceuticals

War-gaming analyst picks the drug distributor over Microsoft, Allscripts and other EMR players

States pile on rules; industry wishes for consistency

Effective integration of a company’s contract strategy with operations can have a big impact on financial performance